Arlene Morris - 14 Jun 2023 Form 4 Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Role
Director
Signature
/s/ Lara Meisner, Attorney-in-Fact for Arlene Morris
Issuer symbol
VRDN
Transactions as of
14 Jun 2023
Net transactions value
$0
Form type
4
Filing time
16 Jun 2023, 19:51:24 UTC
Previous filing
08 Jun 2023
Next filing
22 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRDN Stock Option (Right to Buy) Award $0 +20,000 $0.000000 20,000 14 Jun 2023 Common Stock 20,000 $27.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full upon the earlier to occur of (i) June 14, 2024 or (ii) the Issuer's 2024 annual meeting of stockholders, subject to Reporting Person's continued service on the Board.